ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,504 | -13.0% | 600 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $14,370 | +27.3% | 600 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $11,292 | +18.2% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $9,552 | -13.2% | 600 | -14.3% | 0.01% | -16.7% |
| Q3 2022 | $11,000 | +10.0% | 700 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $10,000 | -41.2% | 700 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $17,000 | +6.2% | 700 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $16,000 | +33.3% | 700 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $12,000 | -66.7% | 700 | -17.6% | 0.01% | -73.9% |
| Q4 2019 | $36,000 | – | 850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |